Table 3.
Is comparing the group of patients with a limited TAP without a valve (A), with group (B) who had a monocuspid TAP (Contegra).
| Variable | Group A | Group B | p value |
|---|---|---|---|
| Pleural effusion no. (%) | (8/48) 16.6% | (1/16) 6.25% | 0.29 |
| Arrhythmias no. (%) | (10) 20% | (4) 25% | 0.72 |
| Pericardial effusion no. (%) | (6) 12.5% | (0) 0% | 0.13 |
| Acute renal failure (with temporary dialysis) no. (%) | (1) 2% | (1) 6.25% | 0.4 |
| New onset of seizure no. (%) | (4) 8.3% | (0) 0% | 0.23 |
| Chylothorax no. (%) | (3) 6.25% | (0) 0% | 0.3 |
| Average inotropes duration (h) | 64.6 ± 58.7 SD | 50.2 ± 68.9 SD | 0.43 |
| Maximum no. of inotropes | 2 ± 0.7 SD | 1.9 ± 0.8 SD | 0.63 |
| Average ventilation time (h) | 50.3 ± 67 SD | 34.8 ± 72 SD | 0.44 |
| Average ICU length of stay (days) | 4.8 ± 3.6 SD | 4.5 ± 4.5 SD | 0.74 |
| Average hospital length of stay (days) | 10.9 ± 7.4 SD | 9.5 ± 7 SD | 0.52 |
| Average of post-operative RVOT max PG (mm Hg) | 17 ± 9 SD | 16.2 ± 7.9 SD | 0.76 |
No: Number, h: hours, max: maximum, PG: pressure gradient, mm Hg: millimeter mercury.